// App-Quantinova.ai

AB1159 (2022) : HYDROXYCHLOROQUINE SHORTAGE AND ITS RELATION TO ANXIETY LEVEL AND DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS DURING COVID-19 PANDEMIC

Researchers

Presenter

  • M. H. Abu-Zaid

Principal Investigators

  • H. Eitta

  • A. Moshrif

  • D. Abdeldaim

  • N. EL Ghobashy

Medical Centers

  • Tanta University, Rheumatology, Tanta, Egypt

  • Ain Shams University, Pathology, Cairo, Egypt

  • Al Azhar university, Rheumatology, Assiut, Egypt

  • Tanta University, public health, Tanta, Egypt

  • Cairo University, Chemical Pathology, Cairo, Egypt

Locations

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Autoimmune (AI)

  • Infectious Diseases (ID)

Disease

  • Lupus

  • Rheumatoid arthritis

  • Inflammatory Arthritis

  • Coronavirus disease

  • Anxiety

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved